Genesis Therapeutics Company

Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.
Technology: Artificial Intelligence, Biotechnology, Information Technology
Industry: Early Drug Development
Headquarters: South San Francisco, California, United States
Founded Date: 2019-11-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 13
Total Funding: 56100000
Estimated Revenue: $1M to $10M
Last Funding Date: 2020-12-02
Last Funding Type: Series A

Visit Website
Register and Claim Ownership